What is the average price target for TRANSALTA CORP (TAC) stock?
18 analysts have analysed TAC and the average price target is 17.53 USD. This implies a price increase of 38.54% is expected in the next year compared to the current price of 12.65.
NYSE:TAC • CA89346D1078
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TRANSALTA CORP (TAC).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-24 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-10-14 | Jefferies | Maintains | Buy -> Buy |
| 2025-08-05 | TD Securities | Maintains | Buy -> Buy |
| 2025-07-18 | ScotiaBank | Upgrade | Sector Perform -> Sector Outperform |
| 2025-05-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-02-18 | CIBC | Upgrade | Neutral -> Outperformer |
| 2022-12-16 | RBC Capital | Maintains | Outperform |
| 2021-08-12 | National Bank Financial | Maintains | Sector Perform |
| 2021-08-11 | National Bank Financial | Upgrade | |
| 2021-08-11 | RBC Capital | Maintains | Outperform |
| 2021-08-11 | CIBC World Markets | Upgrade | Outperform |
| 2021-08-11 | BMO Capital Markets | Upgrade | |
| 2021-08-11 | TD Securities | Upgrade | Outperform |
| 2021-08-10 | CIBC World Markets | Maintains | Outperform |
| 2021-07-21 | CIBC World Markets | Upgrade | Outperform |
| 2021-06-01 | BMO Capital Markets | Upgrade | Outperform |
| 2021-05-25 | Credit Suisse | Upgrade | Sector Perform |
| 2021-05-14 | RBC Capital | Upgrade | Outperform |
| 2021-05-14 | CIBC World Markets | Maintains | Outperform |
| 2021-05-14 | BMO Capital Markets | Upgrade | Market Perform |
| 2021-05-04 | CIBC World Markets | Maintains | Outperform |
| 2021-04-20 | CIBC World Markets | Upgrade | Outperform |
| 2021-04-16 | Sbank | Upgrade | Outperform |
| 2021-03-26 | RBC Capital | Maintains | Outperform |
| 2021-03-10 | National Bank | Downgrade | SECTOR PERFORM |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.355B 12.74% | 2.845B -15.20% | 2.405B -15.47% | 2.1B -12.68% | 2.272B 8.19% | 2.584B 13.73% | N/A | |
| EBITDA YoY % growth | 1.662B 45.92% | 1.186B -28.64% | 706M -40.47% | 1.014B 43.63% | 1.1B 8.48% | 1.237B 12.45% | 1.417B 14.55% | |
| EBIT YoY % growth | 1.041B 92.78% | 655M -37.08% | 127M -80.61% | 471.57M 271.31% | 537.49M 13.98% | 647.95M 20.55% | N/A | |
| Operating Margin | 31.03% | 23.02% | 5.28% | 22.46% | 23.66% | 25.08% | N/A | |
| EPS YoY % growth | 2.47 24,600.00% | 0.56 -77.33% | 0.20 -64.29% | 0.18 -9.82% | 0.53 191.38% | 1.00 90.51% | N/A |
All data in CAD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.06 -35.63% | 0.17 -7.01% | -0.03 -41.62% | 0.00 104.29% | 0.15 140.00% | 0.14 -13.85% | 0.15 645.45% | 0.13 5,100.00% | 0.22 40.00% | 0.48 230.71% | 0.03 -78.00% | 0.26 96.92% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 241.57M -7.44% | 291.24M -5.13% | 233.32M -50.25% | 257.02M -52.58% | 277.38M 14.82% | 300.33M 3.12% | 257.16M 10.22% | 288M 12.05% | 311.61M 12.34% | 370.03M 23.21% | 291.54M 13.37% | 345.34M 19.91% |
| EBIT Q2Q % growth | 77.25M -32.83% | 154.5M 1,304.55% | 110.73M 191.39% | 114.85M 410.41% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in CAD
18 analysts have analysed TAC and the average price target is 17.53 USD. This implies a price increase of 38.54% is expected in the next year compared to the current price of 12.65.
TRANSALTA CORP (TAC) will report earnings on 2026-05-06.
The number of analysts covering TRANSALTA CORP (TAC) is 18.